Mapping the quality of medical products across the world: The new Medicine Quality Monitoring (MQM) Globe by IDDO

The Medicine Quality Monitoring (MQM) Globe is a new interactive tool developed by the Infectious Diseases Data Observatory (IDDO) to track the quality of medical products across the world. The issue of substandard and falsified medicines is a serious concern, but surveillance of these products is limited in most parts of the world, and incidents and alerts are often not adequately covered by news outlets. This lack of awareness and understanding can lead to serious Read more…

Social media best practices for health authorities

Illegal trade of substandard and false medicines in Europe mainly takes place online. The internet is used to sell medicines illegally and to spread false or misleading claims about the products being sold. Patients and consumers rarely check official websites to verify medical claims, making them susceptible to buying false and poor-quality products. Social media can be a powerful tool for communication to raise awareness on the issue. For this reason, the Committee of Experts Read more…

WHO Medical Product Alert N°2/2023: TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1%

The WHO has issued a medical product alert for batches of eye ointment manufactured in India. The product was supplied to at least 55 countries under different labels.   A visual examination of random samples by five international recipients showed a range of quality issues within various batches (e.g. different shaped, sized and coloured particles on the nozzle, cap and in the ointment).   Currently there is no established evidence of any adverse effects caused by the Read more…

Improved knowledge on substandard and falsified medicines – a course for pharmacy students in sub-Saharan Africa

The lack of formal training on substandard and falsified (SF) medical products among pharmacists is a significant problem that needs to be addressed to combat the global health threat represented by SF products.   A recent study conducted in Sub-Saharan Africa among 355 pharmacy students shows t hat a dedicated educational course for undergraduate pharmacy students significantly enhanced their knowledge of SF medicines. Improvement was also confirmed through self-assessment, and the course was very well-received among Read more…

UNODC Assessment – Trafficking in Medical Products in the Sahel

The UNODC Assessment of Trafficking in Medical Products in the Sahel brought to light a terrible situation of substandard and falsified medicines in the area.  While there are no reliable estimates of the overall quantities of medical products that are trafficked in different ways and forms in the Sahel countries, studies point to a percentage of substandard and falsified medicines in the medical market of between 19 and 50 per cent. Some 40 per cent Read more…

Substandard & Falsified Medicines Block The Way To Universal Health Coverage

If we had the opportunity to deliver a statement at the 152nd WHO Executive Board meeting, this is what we would have said in relation to Agenda item 5. Universal Health Coverage Substandard & Falsified Medicines block the way to Universal Health Coverage Reaching the shared and noble objectives to which Universal Health Coverage aspires requires not just ensuring that products are available when and where they are needed but also that these products are Read more…

152nd Executive Board – Statements supported by Fight the Fakes Alliance

We support and echo the statements delivered by our members on key agenda item 7. Substandard and falsified medical products (EB152/7) at the 152nd Executive Board Meeting of the World Health Organization. No more room for error –  Stepping up the fight against substandard and fake medical products is urgent! Read the statements below.   World Heart Federation Meeting:  152nd EB Individual Statements Agenda Item: 7. Substandard and falsified medical products (EB152/7)Statement:Honourable Chair, Distinguished Delegates, This Read more…

Fight the Fakes Week flagship event featured in Health Policy Watch

Fight The Fakes Week flagship event: Keeping patients safe – securing the global medicines supply chain Homicide Charges for Those Making Harmful Fake Medicine? Article originally published on Health Policy Watch by Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Read more…

Subscribe to our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.